Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
ECMP 2024
Programm
Poster
Personen
Suche
DE
Zurück
Poster session
Poster session
Diagnostic and therapeutic nuclear medicine I
Termin
Datum:
12.09.2024
Zeit:
14:00
–
15:00
Ort / Stream:
Poster Terminal 4 (1st floor)
Vorsitz
Dr. Manuel Bardiès
Montpellier / FR
Programm
14:00
–
14:04
3 Min.
1 Min.
Eposter presentation
PP11.01
AlphaMet: A European project on metrology for emerging targeted alpha therapies
Johannes Tran-Gia (Würzburg / DE)
Dr. Wei Bo Li (Oberschleißheim / DE)
Diagnostic and therapeutic nuclear medicine, Innovative radiotherapy and medical imaging
14:04
–
14:08
3 Min.
1 Min.
Eposter presentation
PP11.02
Deciphering the enigma of atypical forms of Alzheimer's disease by employing connectomics in the context of early and late-phase Amyloid PET and [18F]FDG PET Imaging
Dr. Alessio Cirone (Genoa / IT)
Artificial intelligence, Diagnostic and therapeutic nuclear medicine
14:08
–
14:12
3 Min.
1 Min.
Eposter presentation
PP11.03
Large-cohort evaluation of normal organ uptake in 177Lu-PSMA therapy and relationship to total tumour burden on quantitative SPECT/CT using deep learning
Lachlan McIntosh (Melbourne / AU)
Artificial intelligence, Diagnostic and therapeutic nuclear medicine
14:12
–
14:16
3 Min.
1 Min.
Eposter presentation
PP11.04
CT organ dose estimation in whole-body PET/CT – Comparison of a patient-specific Monte Carlo and a computational phantom-based CT dosimetry tool
Gwenny Verfaillie (Ieper / BE)
Diagnostic and interventional radiology, Diagnostic and therapeutic nuclear medicine
14:16
–
14:20
3 Min.
1 Min.
Eposter presentation
PP11.06
Impact of PET image reconstruction parameters on the recovered total activity for 90Y radioembolization
Iago Mosquera Cereijo (Valencia / ES)
Clinical radiotherapy, Diagnostic and therapeutic nuclear medicine
14:20
–
14:24
3 Min.
1 Min.
Eposter presentation
PP11.07
Assessment of
68
Ga-PSMA receptor saturation after therapeutic infusion using a PBPK model
Professor Gerhard Glatting (Ulm / DE)
Clinical radiotherapy, Diagnostic and therapeutic nuclear medicine
14:24
–
14:28
3 Min.
1 Min.
Eposter presentation
PP11.08
LU-177 PSMA therapy without hospitalisation: A feasibility study based on the use of dedicated toilet filter systems
Dr. Caterina Ghetti (Parma / IT)
Diagnostic and therapeutic nuclear medicine, Radiation protection
14:28
–
14:32
3 Min.
1 Min.
Eposter presentation
PP11.09
Digital PET optimisation, process and pitfalls
Eamon Loughman (Dublin / IE)
Diagnostic and therapeutic nuclear medicine, Radiation protection
14:32
–
14:36
3 Min.
1 Min.
Eposter presentation
PP11.10
Influence of OSEM reconstruction parameters and MC collimator modeling on
166
Ho activity quantification in SPECT/CT imaging
João Santos (Porto / PT)
Diagnostic and therapeutic nuclear medicine, Innovative radiotherapy and medical imaging
14:36
–
14:40
3 Min.
1 Min.
Eposter presentation
PP11.11
A practical method for estimating residual activity in radioembolization with 90Y microspheres
Iago Mosquera Cereijo (Valencia / ES)
Clinical radiotherapy, Diagnostic and therapeutic nuclear medicine
14:40
–
14:44
3 Min.
1 Min.
Eposter presentation
PP11.12
Comparison of dosimetry software packages for planar image-based dosimetry in prostate cancer patients with
177
Lu radioligand therapy
Professor Krisanat Chuamsaamarkkee (Bangkok / TH)
Diagnostic and therapeutic nuclear medicine
14:44
–
14:48
3 Min.
1 Min.
Eposter presentation
PP11.13
Validation of Monte-Carlo-based Iterative SPECT Reconstruction: Comparison against standard clinical reconstruction algorithms
Ivan Pribanić (Rijeka / HR)
Diagnostic and therapeutic nuclear medicine, Innovative radiotherapy and medical imaging
14:48
–
14:52
3 Min.
1 Min.
Eposter presentation
PP11.14
Comparison of dose indicators in PET scans for different radiopharmaceuticals
Eva González Kölmel (Santiago de Compostela / ES)
Diagnostic and therapeutic nuclear medicine, Radiation protection
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz